Jason Pontin

Decode and design the interfaces of life

Building biology with AI.

We work to map the microbiome and illuminate interactions foundational to the health of humanity.

Aquafortus Technologies Limited is a company at the cutting edge of water technology. Aquafortus has developed a novel non-thermal liquid to liquid crystallizer (the ABXTM), that reduces wastewater brine to dry salt and clean water. Zero Liquid Discharge (ZLD) means that practically all the water is recovered from the wastewater and that the remaining waste can be shovelled onto a truck for final disposal. The ZLD market has grown rapidly due to government regulations globally that compelled heavily polluting and water-intensive industries to go ZLD or face massive fines and ultimately be shut down. Aquafortus’ ABXTM system is a novel liquid-to-liquid crystallizer that promotes the formation of salt crystals via a proprietary direct contact crystallization process using Aquafortus’ patented solutions, which are called the Aquafortus Absorbent and the Aquafortus Regenerant. The ABXTM system efficiently reduces highly concentrated brines to dry salt and produces clean water. The Aquafortus Absorbent can precipitate all salts commonly found in industrial wastewaters, including troublesome salts like lithium chloride. The Aquafortus ABXTM system is the only known continuous and regenerable process that can wholly replace energy intensive Thermal Crystallizers in a ZLD treatment train.

Recycleye delivers AI-powered sorting equipment and analytics to increase profitability for waste management globally. Combining pioneering robotic and optical sorters with a solid understanding of waste, were lowering materials sorting costs and increasing plant performance. Using AI that’s as accurate as a human eye with a unique database of billions of waste images to precisely detect materials, Recycleye dashboards provide insights for data-driven decisions at strategic and operational levels. Our team is forging new revenue streams for material recovery businesses across Europe and the USA to change the economics of recycling. Were always on the lookout for exceptional new members for our growing team, especially Software Engineers. Check the Careers page on our website for opportunities to work with us, or send your CV to our HR team at Careers@recycleye.com.

DVLP Medicines is building a new infrastructure for drug development on the blockchain. By digitizing drug assets, financing, and development workflows, we are reimagining and accelerating the entire process to turn more molecules into medicines.

We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of lifes most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select druggable targets and develop transformational medicines.

We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists​ ability to use synthetic biology on a scale not currently possible.

Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the worlds most advanced generative AI platform for peptide therapeutics.

Totus Medicines is applying revolutionary chemical biology technologies to create life-changing covalent therapeutics for untreatable diseases.

Decode and design the interfaces of life

Building biology with AI.

DCVC and its principals have backed brilliant people changing global-scale industries for over twenty years, helping create tens of billions of dollars of wealth for founders, employees, and our investors while also making the world a markedly better place. DCVC brings to bear a unique model that unites a team of experienced venture capitalists with more than 35 technology executives and experts (CTOs, CIOs, Chief Scientists, Principal Engineers, Professors at Stanford and Berkeley) with significant tenures at top 100 technology companies and research institutions worldwide. DCVC focuses on seed, Series A, and growth stage companies that apply deep compute, big data and IT infrastructure technologies to transform giant industries. Learn more about us at www.dcvc.com, read our thinking at https://medium.com/@dcvc, and follow us on twitter at @dcvc.

We work to map the microbiome and illuminate interactions foundational to the health of humanity.

Aquafortus Technologies Limited is a company at the cutting edge of water technology. Aquafortus has developed a novel non-thermal liquid to liquid crystallizer (the ABXTM), that reduces wastewater brine to dry salt and clean water. Zero Liquid Discharge (ZLD) means that practically all the water is recovered from the wastewater and that the remaining waste can be shovelled onto a truck for final disposal. The ZLD market has grown rapidly due to government regulations globally that compelled heavily polluting and water-intensive industries to go ZLD or face massive fines and ultimately be shut down. Aquafortus’ ABXTM system is a novel liquid-to-liquid crystallizer that promotes the formation of salt crystals via a proprietary direct contact crystallization process using Aquafortus’ patented solutions, which are called the Aquafortus Absorbent and the Aquafortus Regenerant. The ABXTM system efficiently reduces highly concentrated brines to dry salt and produces clean water. The Aquafortus Absorbent can precipitate all salts commonly found in industrial wastewaters, including troublesome salts like lithium chloride. The Aquafortus ABXTM system is the only known continuous and regenerable process that can wholly replace energy intensive Thermal Crystallizers in a ZLD treatment train.